WBGE reductions in endogenous ICAM-1 expression in A549 cells involves

Recent studies suggest that ICAM-1 is a target of miR-221/-222, and both miRNAs

regulate ICAM-1 expression (Duan et al., 2013). miR-221 and miR-222 are encoded in tandem on X chromosomes and are conserved miRNAs with significant homology between them. According to TargetScan.org (http://www.targetscan.org), miR-221 and miR-222 are complementary to the ICAM-1 3’UTR and extend between 413 and 419 (Fig. 13A). Furthermore, we examined whether posttranscriptional regulation by

miR-221/-222 was critical for the ICAM-1 expression in A549 cells treated with TNF-

doi:10.6342/NTU201701930

and WBGE. There were no significant changes in the levels of both miR-221/-222 expression in A549 cells following TNF- stimulation for 4 h (Fig. 13B). To test the role of miR-221/-222 in TNF--mediated induction of ICAM-1, A549 cells were transfected with miR-221/-222 precursors for 44 h, followed by exposure to TNF- for 4 h with subsequent assessment of ICAM-1 protein expression via Western blot.

Transfection of cells with a precursor miR-221 or miR-222 sequence, however, did not affect TNF--induced ICAM-1 (Fig. 14A), p-p65, p-PI3K and p-IκB expression (Fig.

14B). We also found that miR-221 or miR-222 precursors had no effect on adhesion of U937 cells to TNF-treated A549 cells (Fig. 15).

Interestingly, we found that WBGE treatment significantly increased miR-221/-222 expression (Fig. 13B). In addition, WBGE treatment significantly reduced endogenous ICAM-1 expression (Fig. 2B). Additionally, the phosphorylation of PI3K, AKT, p65, and IB decreased after WBGE treatment compared to the control group (Figs. 7A, 9A, 9B). Therefore, we investigated whether miR-221/-222 was involved in the effects of WBGE on endogenous ICAM-1 expression in A549 cells. As shown in Fig. 16, the precursor of miR-222 significantly attenuated endogenous

ICAM-1 expression in A549 cells. An increase in the phosphorylation of AKT, p65, and IκB was detected in A549 cells, which was significantly ameliorated in cells transfected with a miR-222 precursor (Fig. 16). To determine the functional relevance of

miR-221/-222-regulated expression of ICAM-1 in A549 cells, monocyte adhesion assays were performed in the presence of A549 cells transfected with miR-221 or miR-222 precursors. As shown in Fig. 17, there was a significant reduction of monocyte adhesion in cells transfected with either of the precursors. We also found that ICAM-1 expression was downregulated by AKT, PI3K and p-65 inhibitors (Fig. 18). These data further corroborate the fact that WBGE-mediated upregulation of miR-222 is involved

doi:10.6342/NTU201701930

in endogenous expression of ICAM-1 in A549 cells and influences monocyte adhesion.

3.6 WBGE reduces ICAM-1 expression in lung tissues of TNF-α-treated WT mice

To determine the effects of WBGE on ICAM-1 expression in vivo, WT mice and

miR-221/-222 KO mice were fed WBGE for 5 days followed by an either an injection of TNF-α for 1 day or no injection; then, RT-PCR, Western blot and

immunohistochemical staining were performed to detect the expression of

miRNA-221/-222, ICAM-1 protein, and ICAM-1 in sections of lung tissues. As shown in Fig. 19, TNF-α treatment significantly reduced the levels of miRNA-222 expression.

WBGE significantly increased miRNA-221/-222 expression in lung tissues with or without TNF-α treatment. The levels of miRNA-221/-222 were very low for lung tissues of four groups in miRNA-221/-222 KO mice. As shown in Fig. 20A, TNF-α treatment significantly induced ICAM-1 expression, whereas WBGE decreased ICAM-1 expression in lung tissues of WT mice. Furthermore, TNF-α induced higher ICAM-1 expression in miRNA-221/-222 KO mice compared to wild-type mice. WBGE had little effect on ICAM-1 expression. As shown in Fig. 20B, in the control and

WBGE-treated groups, weak ICAM-1 staining was seen in the lung tissues, whereas in the TNF-α-treated group, strong ICAM-1 staining was seen in the lung tissues after immunohistochemical staining. In contrast, preadministration of WBGE resulted in weak ICAM-1 staining in the TNF-α-treated animals (WBGE /T). ICAM-1 expression was stronger in TNF-α-treated miR-221/-222 KO mice compared with the

TNF-α-treated WT animals. Additionally, WBGE mildly decrease ICAM-1 expression in miR-221/-222 KO mice. These beneficial effects of WBGE were lost in

miR-221/-222 KO mice.

doi:10.6342/NTU201701930

第四章討論

In this study, we demonstrated that WBGE treatment significantly decreased ICAM-1 expression and adhesion of monocyte U937 to TNF-α-stimulated A549 cells.

The influence was partially mediated through inhibition of the phosphorylation of PI3K/AKT/NF-κB/IB. Moreover, WBGE treatment significantly reduced endogenous ICAM-1 expression in A549 cells without TNF-α treatment. The effect was mediated through upregulation of miR-222 expression as well as decreased phosphorylation of PI3K/AKT/p65/IB. Furthermore, WBGE attenuated ICAM-1 expression and

upregulated miR-221/-222 expression in the lung tissues of mice with or without TNF-α treatment but had little effect in miR-221/-222 KO mice. The protection of lung cells by WBGE is due to the inhibition of PI3K/AKT/p65/IB and ICAM-1 by miR-221/-222.

Inflammation is a central feature of respiratory disorders. Substantial evidence has demonstrated that WBG is not only a functional food but also has anti-diabetic,

anti-inflammatory, and anti-tumor activities(Chao et al., 2014; Bai et al., 2016; Wu et al., 2009). The ethanol extract of WBG reduced iNOS and IL-1β expression in

LPS-treated RAW264.7 macrophages (Lii et al., 2009). Addition of WBG lyophilized powder reduced the inflammation biochemical markers IL-1, IL-6 and TNF-α in LPS-treated mice (Chao et al., 2014). A triterpenoid isolated from WBG exhibited an antiproliferative effect on breast cancer cells (Bai et al., 2016). The triglycerides and dicarboxylic acids in bitter gourd inhibited PGE2 production, which is a

proinflammatory mediator, in LPS-treated RAW264.7 macrophages (Wu et al., 2009).

This study is the first to report that WBGE reduced ICAM-1 expression in

TNF-α-stimulated A549 cells and lung tissues in mice. In addition, WBGE inhibited leukocyte adhesion to TNF-α-stimulated A549 cells. We also showed that the

doi:10.6342/NTU201701930

phytoconstituent from WBGE contained charantin, which is one of the major active compounds in WBGE. Charantin reduced ICAM-1 expression in TNF-α-stimulated A549 cells. These data indicated that the downregulation of ICAM-1 expression by WBGE may be partially attributed to the rich fraction of charantin, which is a natural steroidal glycoside. Because ICAM-1 has been reported as an important modulator of inflammation in epithelial cells of the respiratory airway and leukocyte adhesion (Lee et al., 2013), our experiments provide evidence that WBGE has the capability to reduce ICAM-1 expression and monocyte adhesion and may serve as a therapeutic reagent in lung inflammation.

MAPK and PI3K/AKT pathways played an important role in the expression of proinflammatory mediators and inflammatory cell recruitment, which led to the initiation and progression of lung inflammation (Lee et al., 2013). The present study demonstrated that TNF-α caused strong phosphorylation of three MAPK subtypes and PI3K/AKT in A549 cells, as reported in previous studies (Lee et al., 2013; Oh and Kwon, 2009). However, the involvement of their activation in the protective mechanism of WBGE has yet to be determined. Our results showed that WBGE significantly

decreased TNF-α-induced PI3K and AKT phosphorylation, whereas WBGE had no effects on TNF-α-induced MAPK phosphorylation. The increase in ICAM-1 expression induced by TNF-α was markedly suppressed in the presence of PI3K inhibitor or AKT inhibitor. Thus, one of the mechanisms through which WBGE reduces TNF-α-induced ICAM-1 expression involves a reduction in PI3K/AKT activation. Consistent with our results, bitter melon juice was effective at decreasing AKT/PI3K phosphorylation and viability of pancreatic cancer cells (Somasagara et al., 2015). A triterpenoid isolated from WBG induced breast cancer cell apoptosis through the downregulation of AKT signaling (Bai et al., 2016). However, our findings do not agree with several reports.

doi:10.6342/NTU201701930

The butanol fraction of bitter gourd suppressed phosphorylation of p38, JNK, and ERK in LPS-treated RAW 264.7 cells (Kobori et al., 2008). The preventive effects of bitter melon against insulin resistance and diabetes are associated with the inhibition of JNK pathway in the livers of rats fed a high-fat diet (Yang et al., 2015 ). The differences between these results in terms of the pathways involved may be related to differences in the cell type, inducers, and cytokines.

PI3K/AKT has been shown to phosphorylate NF-κB transcription activity, which is the major activator in the regulation of inflammatory responses (Lee and Yang, 2013). Our results demonstrated that activation of NF-κB is necessary for TNF-α-induced ICAM-1 expression in A549 cells and that this activation is similar to results from previous reports (Oh and Kwon, 2009). Our study further demonstrated that the

WBGE-decreased ICAM-1 expression in TNF--treated A549 cells was mediated through inactivation of NF-κB binding activity. The result was similar to the previous reports. Bitter melon preventive effects against insulin resistance and diabetes are associated with the modulation of NF-B pathway in high-fat-fed rats (Yang et al., 2015). Momordica charantia fruit extract protects cardiomyocytes from TNF--induced apoptosis partially through inhibition of the NF-B pathway (Hu et al., 2016). Wild bitter gourd lyophilized powder significantly inhibited the expression levels of NF-B, iNOS, and COX-2 in LPS-treated mice (Chao et al., 2014). Furthermore, inducible NF-κB activation is controlled by signals involved in IκB phosphorylation and its dissociation from the inactive cytoplasmic complex, followed by translocation of the active p50/p65 dimer to the nucleus and induced gene expression (Choi et al., 2012).

We demonstrated that the WBGE-induced decrease in ICAM-1 expression was mediated through inhibition of IκB phosphorylation and p65 translocation. Together these results suggest that WBGE treatment inactivates TNF-α-induced PI3K/AKT

doi:10.6342/NTU201701930

phosphorylation and NF-B /IB pathways as well as subsequently suppresses ICAM-1 expression, which results in decreased binding of leukocytes. Because the inflammation is involved in many kinds of chronic and acute lung tissues and it is characterized by the production of proinflammatory cytokines, the enhanced monocyte adhesion as well as the accompanying inflammatory signal (Lee and Yang, 2013), WBGE may provide a new natural therapeutic approach for the prevention of inflammation and lung diseases.

MicroRNAs have been reported to play a key role in mediating cellular responses under various stress conditions in lung diseases (Alipoor et al., 2016). COPD patients have lower miRNA-222 expression (Ikari et al., 2015). Recent reports indicated that ICAM-1 expression was controlled by a number of miRNA species, such as miR-221 and miR-222(Hu et al., 2010; Duan et al., 2013). These miRNAs are complementary to the ICAM-1 3’UTR region and modulate ICAM-1 expression at the posttranscriptional level by binding to the untranslated region(Marques-Rocha, 2015). The increased ICAM-1 expression in human immunodeficiency virus-1 (HIV-1) Tat-treated

endothelial cells was concomitant with a reduction in miR-221/-222 expression(Duan et al., 2013). IFN-γ suppressed miR-221 and resulted in increased ICAM-1 expression in cholangiocytes (Hu et al, 2010). Another study demonstrated that the upregulation of ICAM-1 protein in human intrahepatic biliary epithelial cells following the parasite infection involves downregulation of miRNA-221 (Gong et al., 2011). Endothelial microparticles promote an anti-inflammatory effect by reducing endothelial ICAM-1 expression through higher amounts of miR-222 (Jansen et al., 2015). In the present study, we showed that A549 cells treated with TNF- or with the TNF-+WBGE treatment did not alter the miRNA-221/-222 levels. Interestingly, only WBGE treatment can increase miRNA-221/-222 levels and decrease endogenous ICAM-1 expression in A549 cells. Furthermore, the overexpressed miRNA-222 levels significantly reduced

doi:10.6342/NTU201701930

the phosphorylation of PI3K/AKT and IB /NFB-p65 as well as the monocyte

adhesion. Furthermore, the in vivo study demonstrated that TNF- treatment decreased the miRNA-221/-222 levels and increased the ICAM-1 expression, whereas WBGE pretreatment increased the miRNA-221/-222 levels and attenuated the ICAM-1 expression in lung tissues. In contrast, WBGE treatment showed little effect on ICAM expression in lung tissues of miR-221/-222 KO mice with or without TNF- treatment.

These different results between in vivo and in vitro studies suggest that the effects of WBGE and miR-221/-222 expression probably did not depend on only one cell type.

The result in the in vivo study may be due to the component cells of lung tissues, including type I cells, endothelial cell, smooth muscle cells, and macrophages. Further investigations are needed to better understand the role of WBGE plays in the prevention and treatment of inflammatory lung diseases.

In summary, this study provides the first evidence that WBGE reduces ICAM-1 expression under inflammatory conditions both in vitro and in vivo and decreases leukocyte adhesion to alveolar epithelial cells. We also showed that WBGE inhibited endogenous ICAM-1 expression in A549 cells through blockade of

PI3K/AKT/NF-κB/IκB phosphorylation and regulation of miRNA-222 expression.

Based on these findings, WBGE should be considered a novel therapeutic agent for targeting epithelial activation in pulmonary inflammation. Taken together, the

pleiotropic mechanism against inflammation highlights the usefulness of WBGE as a healthy food.

doi:10.6342/NTU201701930

參考資料

Alipoor, S.D., Adcock, I.M., Garssen, J., Mortaz, E., Varahram, M., Mirsaeidi, M., Velayati, A., 2016. The roles of miRNAs as potential biomarkers in lung diseases.

Eur. J. Pharmacol. 791, 395-404.

Bai, L. Y., Chiu, C.F., Chu, P.C., Lin, W.Y., Chiu, S.J., Weng, J.R., 2016. A triterpenoid from wild bitter gourd inhibits breast cancer cells. Sci. Rep. 6, 22419.

Chao, C.Y., Sung, P.J. Wan, W.H., Kuo, Y.H., 2014. Anti-inflammatory effect of momordica charantia in sepsis M\mice. Molecules. 19, 12777-12788.

Chaturvedi, P., 2012. Antidiabetic potentials of momordica charantia: multiple mechanisms behind the effects. J. Med. Food 15, 101-107.

Chen, C.C., Chou, C.Y., Sun, Y.T., Huang, W.C., 2001. Tumor necrosis factor α-induced activation of downstream NF-κB site of the promoter mediates epithelial ICAM-1 expression and monocyte adhesion: Involvement of PKCα, tyrosine kinase, and IKK2, but not MAPKs, pathway. Signal. 13, 543-553.

Choi, K.W., Um, S.H., Kwak, J.H., Park, H.J., Kim, K.H., Moon, E.Y., Kwon, S.T., Pyo, S., 2012. Suppression of adhesion molecule expression by phenanthrene-containing extract of bulbils of Chinese Yam in vascular smooth muscle cells through inhibition of MAPK, Akt and NF-κB. Food Chem. Toxicol. 50:2792–804.

Demir, T., Yalcinoz, C., Keskinel, I., Demiröz, F., Yildirim, N., 2002. sICAM-1 as a serum marker in the diagnosis and follow-up of treatment of pulmonary tuberculosis. Int. J. Tuberc. Lung Dis. 6,155-159.

Desai, S., Tatke, P., 2015. Charantin: An important lead compound from Momordica charantia for the treatment of diabetes. J. Pharmacogn. Phytochem. 3, 163-166.

Dandawate, P.R., Subramaniam, D., Padhye, S.B., Anant, S., 2016. Bitter melon: a

doi:10.6342/NTU201701930

panacea for inflammation and cancer. Chin. J. Nat. Med. 2016, 14, 0081-0100.

Duan, M., Yao, H., Hu, G., Chen, X., Lund, A.K., Buch, S., 2013. HIV Tat Induces Expression of ICAM-1 in HUVECs: Implications for miR-221/-222 in HIV-Associated Cardiomyopathy. PLoS. One 8, 1-11.

Duirham, A.L., Caramori, G., Chung, K.F., Adcock, I. M., 2015. Targeted anti-inflammatory therapeutica astham and chronic obstructive luing disease. Transl.

Res. 67, 192-203.

Gong, A.Y., Hu, G., Zhou, R. Liu, J., Feng, Y., Soukup, G.A. , Chen ,X.M., 2011.

MicroRNA-221 controls expression of intercellular adhesion molecule-1 in epithelial cells in response to Cryptosporidium parvum infection. Int. J. Parasit. 41, 397-403.

Hu, G., Gong, A. Y., Liu, J., Zhou, R., Deng, C., Chen, X. M., 2010. miR-221 suppresses ICAM-1 translation and regulates interferon-γ-induced ICAM-1 expression in human cholangiocytes. Am. J. Physiol. Gastroint. Liver 298, G542–G550.

Hu, H., Liu, Y., Kong, B., Fan, Y., Wang, Z., Peng, J., Xiong, X., Mei, Y., Liu, W., Huang, H., 2016. Protective effect of momordica charantia fruit extract on TNF α-induced NF-κB activation and cardiomyocyte apoptosis. Int. J. Clin. Exp. Med. 9, 5951-5959.

Ikari, J., Smith, L.M., Nelson, A.J., Iwasawa, S., Gunji, Y., Farid, M., Wang, X., Basma, H., Feghali-Bostwick, C., Liu, X., DeMeo, D.L., Rennard, S. I., 2015. Effect of culture conditions on microRNA expression in primary adult control and COPD lung fibroblasts in vitro. In Vitro Cell Dev. Biol. Anim. 51, 390-399.

Jansen, F., Yang, X., Baumann, K., Przybilla, D, Schmitz, T., Flender, A., Paul, K.,

doi:10.6342/NTU201701930

Alhusseiny, A., Nickenig, G., Werner, N., 2015. Endothelial microparticles reduce ICAM-1 expression in a microRNA-222-dependent mechanism. J. Cell Mol. Med.

19, 2202-2214.

Lee, I.T., Lin, C.C., Lee, C.Y., Hsieh, P.W., Yang, C.M., 2013. Pertective effects of (─)-epigallocatechin-3-gallate against TNF-α-induced lung inflammation via ROS-dependent ICAM-1 inhibition. J. Nutr. Biochem. 24, 124-36.

Lee, I.T., Yang, C.M., 2013. Inflammatory signalings involved in airway and pulmonary disease. Mediat. Inflamm. 791231.

Lii, C.K., Chen, H.W., Yun, W.T., Liu, K.L., 2009. Suppressive effects of wild bitter gourd (Momordica charantia Linn. var. abbreviate ser.) fruit extracts on inflammatory responses in RAW264.7 macrophages. J. Ethnopharmacol. 122, 227-233.

Lu, K.H., Tseng, H.C., Liu, C.T., Huang, C.J., Chyuan, J.H., Sheen, L.Y., 2014. Wild bitter gourd protects against alchoholic fatty liver in mice by attenuating oxidative stress and inflammatory responses. Food Funct. 5, 10271037.

Marques-Rocha, JL, Samblas, M, Milagro, FI, Bressan, J, Martínez, JA, Marti, A.

Noncoding RNAs, cytokine, and inflammation-related diseases. F.A.S.E.B. J.

2015;29:3595-611.

Oh, J.H., Kwon, T.K., 2009. Withaferin A inhibits tumor necrosis factor-α-induced expression of cell adhesion molecules by inactivation of Akt and NF-κB in human pulmonary epithelial cells. Int. Immunopharmacol. 9, 614–619.

Patel, S., Patel, T., Parmar, K., Bhatt, Y., Patel, Y, Patel, N.M., 2010. Isolation, characterization and antimicrobial activity of charantin from momordica charantialinn. Fruit. Int. J. Drug Dev. & Res. 2, 629-634.

Rahman, A., Anwar, K.N., True, A.L., Malik, A.B.. 1999. Thrombin-induced p65

doi:10.6342/NTU201701930

homodimer binding to downstream NF-κB site of the promoter mediates endothelial ICAM-1 expression and neutrophil adhesion. J. Immunol. 162:5466-76.

Sung, H.C., Liang, C.J., Lee, C.W., Yen, F.L., Hsiao, C.Y., Wang, S.H., Jiang-Shieh, Y.

F., Tsai, J. S., Chen, Y.L., 2015. The protective effect of eupafolin against TNF-α-induced lung inflammation via the reduction of intercellular cell adhesion molecule-1 expression. J. Ethnopharmacol. 170, 136–147.

Somasagara, R.R., Deep, G., Shrotriya, S., Patel, M., Agarwal, C., Agarwal, R., 2015.

Bitter melon juice targets molecular mechanisms underlying gemcitabine resistance in pancreatic cancer cells. Int. J. Oncol. 46: 1849-1857.

Upadhyay, A., Agrahari, P., Singh, D.K., 2015. A Review on Salient Pharmacological Features of Momordica charantia. Int. J. Pharmacol. 11, 405-413.

Wu, W.H., Lin, B.Y., Kuo, Y.H., Huang, C.J., 2009. Triglycerides constituted of short and medium chain fatty acids and dicarboxylic acids in Momordica charantia, as well as capric acid, inhibit PGE2 production in RAW264.7. macrophages. Food Chem. 117, 306-311.

Yang, S.J., Choi, J. M., Park, S.E., Rhee, E.J., Lee, W.Y., Oh, K.W., Park, S.W., Park, C.Y., 2015. Preventive effects of bitter melon (Momordica charantia) against insulin resistance and diabetes are associated with the inhibition of NF-κB and JNK pathways in high-fat-fed OLETF rats. The Journal of Nutritional Biochemistry.

26,234–240.

doi:10.6342/NTU201701930

附圖 Figure 1

Figure 1: Characterization of WBGE

(A) The chemical structure of charantin contains

Stigmasta-5,25-dien-3β-yl,β-D-glucopyranoside and β-Sitosteryl glucoside. (B) HPLC chromatogram of WBGE and charantin. The vertical and horizontal axes represent the intensity of the UV absorbance values (mAU) and the retention time (min),

respectively.

doi:10.6342/NTU201701930

Figure 2

Figure 2: The effects of WBGE and charantin on ICAM-1 expression in TNF-α-treated A549 cells

(A) The effects of WBGE and charantin on cell viability were examined by MTT assay.

(B) A549 cells were incubated with the indicated concentration of WBGE (10-80μg/mL) or charantin (0.5-5 μg/mL) for 24 h and then with 3 ng/mL TNF-α for 4 h. The ICAM-1 protein expression levels were measured by Western blot. GAPDH was used as the loading control. The data are expressed as a fold value compared to the control value and are the means ± SEM for five separate experiments. *P < 0.05 compared to the untreated cells. ^†P < 0.05 compared to the TNF-α-treated cells.

doi:10.6342/NTU201701930

Figure 3

Figure 3: The effects of WBGE and charantin on ICAM-1 expression patterns in A549 cells

A549 cells were incubated for 24 h with or without WBGE (80 μg/mL) or charantin (CH, 5 μg/mL) and then were incubated with or without TNF-α (T). ICAM-1 expression was examined by immunofluorescence staining. The nuclei were stained with DAPI. C:

control ; T: treated with TNF- alone; WBGE/T: pretreated with WBGE and then stimulated with TNF-; WBGE: treated with WBGE alone; CH/T: pretreated with charantin and then stimulated with TNF-; CH: treated with charantin alone.Bar = 50 μm.

doi:10.6342/NTU201701930

Figure 4

Figure 4: The effects of WBGE on ICAM-1 promoter activity in A549 cells.

A549 cells were transfected with the ICAM-1 promoter plasmid for 44h and then with 3 ng/mL TNF-α for 4 h. ICAM-1 promoter activity was examined by Luciferase assay.

The data are expressed as a fold value compared to the control value and are the means

± SEM for five separate experiments. *P < 0.05 compared to the untreated cells. ^†P <

0.05 compared to the TNF-α-treated cells.

doi:10.6342/NTU201701930

Figure 5

Figure 5: The effects of WBGE on the adhesion of U937 cells to TNF-α-treated A549 cells

A549 cells were left untreated or pretreated for 24 h with WBGE (80 μg/mL) or anti-ICAM-1 antibodies (1 or 2 μg/mL) for 1 h, and then incubated with 3 ng/mL TNF-α for 4 h. BCECF-AM-labeled U937 cells were added to A549 cells and incubated at 37℃ for 45 min. The adherent cells were photographed with a fluorescent

microscope. Bar = 50 μm. The number of U937 cells bound per high power field in six

doi:10.6342/NTU201701930

randomly selected images was counted. The data are expressed as the means ± SEM for five separate experiments. *P < 0.05 compared to the untreated cells. ^†P < 0.05

compared to the TNF-α-treated cells.

doi:10.6342/NTU201701930

Figure 6

Figure 6: The effects of WBGE on MAPKs phosphorylation in TNF-α-treated A549 cells.

A549 cells were incubated for 24 h with or without 80 μg/mL WBGE, and then incubated with 3 ng/mL of TNF-α for the indicated time. GAPDH was used as the loading control. The data are expressed as a fold value compared to the control value

在文檔中研究Eupafolin和山苦瓜對腫瘤壞死因子刺激肺臟發炎之影響及相關機轉 (頁 79-0)